P-1899. Improvement in Provider Experiences from Baseline to Month 12 with Integrating Cabotegravir Long-Acting (CAB LA) for PrEP into Care in an Implementation Science Trial (PILLAR)Taimur Khan, Nanlesta Pilgrim, Leida Mercado et al.|Open Forum Infectious Diseases|2025Cited by 0